DBV Technologies files 2026 half-year report with France’s AMF

The biopharmaceutical company said the report for the semester ended June 30, 2026 is available in French on its website and through the French market authority.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.